CONSOLIDATED GEMS INC COM STK (DE) (CGEM-1)

CEO:
Employees:
30
LEVEL 8, 580 ST KILDA ROAD, MELBOURNE VICTORIA, AUSTRALIA 3004
011 613 8532 2800

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Cullinan Management, Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Management, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 8.165 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value0
Current Ratio0 EPS Growth0 Quick Ratio0
1 Yr BETA -54.1009 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM0
Altman Z-Score0.0

View recent insider trading info

CONSOLIDATED GEMS INC COM STK (DE) YCharts
Yahoo! Finance finviz

Funds Holding CGEM-1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CGEM-1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EBELING THOMAS

  • Director
 67,504 2021-01-07 0

BAEUERLE PATRICK SEE REMARKS

  • Officer
 0 2021-01-07 0

WEBSTER STEPHEN W

  • Director
 0 2021-01-07 0

KEANE RAYMOND T CHIEF LEGAL OFFICER

  • Officer
 1,624 2021-01-07 0

ROSENBERG ANTHONY

  • Director
 45,002 2021-01-07 0

HUGHES OWEN PRESIDENT AND CEO

  • Officer
  • Director
 503,726 2021-01-07 0

WIGGINTON JON MARC CHIEF MEDICAL OFFICER

  • Officer
 0 2021-01-07 0

UBS ONCOLOGY IMPACT FUND L.P.

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT LP

  • 10% Owner
 0 2021-01-07 0

UBS ONCOLOGY IMPACT FUND L.P.

  • 10% Owner
 0 2021-01-07 0

ZAWEL LEIGH SEE REMARKS

  • Officer
 149,760 2021-01-07 0

SAVILL CORRINE ACTING CHIEF BUSINESS OFFICER

  • Officer
 193,115 2021-01-07 0

MICHAELSON JENNIFER SEE REMARKS

  • Officer
 22,911 2021-01-07 0

TRIGILIO JEFFREY CHIEF FINANCIAL OFFICER

  • Officer
 0 2021-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CULLINAN ONCOLOGY INC CGEM 2021-09-03 22:15:03 UTC -0.8259 0.8959 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 21:45:03 UTC -0.8259 0.8959 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 21:15:03 UTC -0.8259 0.8959 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 20:45:04 UTC -0.8169 0.8869 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 20:15:03 UTC -0.8169 0.8869 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 19:45:03 UTC -0.8169 0.8869 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 19:15:03 UTC -0.8169 0.8869 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 18:45:03 UTC -0.7955 0.8655 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 18:15:02 UTC -0.7955 0.8655 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 17:45:03 UTC -0.7955 0.8655 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 17:15:03 UTC -0.7955 0.8655 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 16:45:04 UTC -0.8022 0.8722 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 16:15:03 UTC -0.8022 0.8722 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 15:45:02 UTC -0.8022 0.8722 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 15:15:03 UTC -0.8022 0.8722 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 14:45:03 UTC -0.5457 0.6157 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 14:15:03 UTC -0.5457 0.6157 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 13:45:03 UTC -0.5457 0.6157 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 13:15:03 UTC -0.5457 0.6157 10000
CULLINAN ONCOLOGY INC CGEM 2021-09-03 12:45:03 UTC -0.5457 0.6157 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments